EU External Trade - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues

The main extra-EU suppliers of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues are 🇺🇸 United States, 🇰🇷 South Korea, 🇯🇵 Japan. 🇺🇸 United States leads with 33.3% of total imports (€98.3M). The HHI concentration index stands at 2241, indicating a Moderate market.

The main extra-EU export markets for Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues are 🇺🇸 United States, 🇨🇳 China, 🇯🇵 Japan. 🇺🇸 United States absorbs 27.1% of European exports (€52.2M).

Within the EU, the leading importers of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues are 🇪🇸 Spain, 🇦🇹 Austria, 🇫🇷 France. 🇪🇸 Spain accounts for 20.0% of EU imports.

In 2025, trade flows diverged: imports were rising (13.4%) while exports were falling sharply (-18.2%), signalling a structural market shift.